Hard to see upwards movement in the near future. Terrible broader market conditions currently. DFS pushed back from Q4 2022 to Q1 2023. Knowing the way these micros operate and seeing as they now mention the optimisation study finishing in Q1 2023, with DFS to follow, wouldn't surprise me if DFS drops in Q2 next year.
- Forums
- ASX - By Stock
- MGT
- Ann: Appointment of AMC to Razorback Definitive Feasibility Study
Ann: Appointment of AMC to Razorback Definitive Feasibility Study, page-27
Featured News
Add MGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.72M |
Open | High | Low | Value | Volume |
14.3¢ | 14.5¢ | 13.5¢ | $19.83K | 137.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 23592 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.5¢ | 76869 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23592 | 0.135 |
2 | 145000 | 0.125 |
2 | 22000 | 0.120 |
4 | 56223 | 0.115 |
4 | 40162 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 76869 | 1 |
0.150 | 119850 | 3 |
0.155 | 29825 | 1 |
0.165 | 20000 | 1 |
0.170 | 8500 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
MGT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online